Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

A government initiative is developing advanced alternative testing methods that use no animals in the pharmaceutical ...

The fresh energy brought by the revitalized research attention offers an opportunity to more closely integrate novel drug discovery, residue monitoring, and ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Automation and artificial intelligence are streamlining everything from regulatory tasks to clinical trials and drug ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

The transition from writing to programming regulatory submissions represents one of the most significant efficiency ...